The Asia Pacific Ambulatory Blood Pressure Monitoring Market would witness market growth of 9.3% CAGR during the forecast period (2018 – 2024).

Ambulatory blood pressure monitoring involves monitoring of patient’s blood pressure over a 24-hour period as they carry out daily activities. These devices help in monitoring of blood pressure levels at different time intervals, usually ranging from 15 to 30 minutes. These devices also used in monitoring patients who are at risk of cardiovascular and cerebrovascular events due to hypertension. The Asia Pacific would be the fastest-growing market during the forecast period. Increase in geriatric patient population, rise in prevalence of different types of diseases such as diabetes and cardiovascular diseases, and high adoption of non-invasive methods for measuring blood pressure are the factors that drive the market in the Asia Pacific region. The region would offer tremendous market potential as there is an increased focus by key players and improving healthcare infrastructure therein.

Based on Product, the market is segmented into Wrist ABPM Devices and Arm ABPM Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs) and Other End users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include SunTech Medical, Inc., GE Healthcare, Welch Allyn, BPL Medical Technologies, Medtronic Inc., Spacelabs Healthcare, Inc. (OSI SYSTEMS, INC.), A&D Company, Ltd., Vaso corporations (Vaso medical), Schiller AG, and Omron Healthcare Company, Ltd.